Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-18-015882

EVP & Chief Financial Officer sold 8,532 shares at $18.72 ($159,712)

  • EVP & Chief Financial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kelly James Patrick · EVP & Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-02-28 Grant or award : show line 1 in the form +40,000 208,066 D
2018-03-01 Sale : show line 2 in the form −8,532 $18.72 $159,712 199,534 D
Open-market sales · 8,532 sh · avg $18.72 · $159,712

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-02-28 Grant or award : show line 3 in the form Employee Stock Option (Right to Buy) +80,000 80,000 D
Loading xslF345X03/doc4.xml…